INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,721,000 | +5.3% | 66,500 | -2.6% | 0.18% | +11.3% |
Q2 2022 | $3,535,000 | -28.8% | 68,300 | 0.0% | 0.16% | -13.1% |
Q1 2022 | $4,963,000 | -38.5% | 68,300 | 0.0% | 0.18% | -36.0% |
Q4 2021 | $8,076,000 | -11.9% | 68,300 | 0.0% | 0.29% | -20.1% |
Q3 2021 | $9,162,000 | -17.1% | 68,300 | 0.0% | 0.36% | -14.1% |
Q2 2021 | $11,058,000 | +101.8% | 68,300 | 0.0% | 0.42% | +118.3% |
Q1 2021 | $5,481,000 | +47.5% | 68,300 | 0.0% | 0.19% | +14.4% |
Q4 2020 | $3,716,000 | +173.6% | 68,300 | 0.0% | 0.17% | +198.2% |
Q3 2020 | $1,358,000 | -5.4% | 68,300 | 0.0% | 0.06% | -29.1% |
Q2 2020 | $1,436,000 | +72.0% | 68,300 | 0.0% | 0.08% | +29.5% |
Q1 2020 | $835,000 | +11.2% | 68,300 | +33.4% | 0.06% | +45.2% |
Q4 2019 | $751,000 | +41.7% | 51,200 | +29.0% | 0.04% | +35.5% |
Q3 2019 | $530,000 | +31.2% | 39,700 | +60.7% | 0.03% | +34.8% |
Q2 2019 | $404,000 | -96.9% | 24,700 | +11026.1% | 0.02% | -54.9% |
Q1 2019 | $13,000,000 | +7244.6% | 222 | -98.3% | 0.05% | +325.0% |
Q4 2018 | $177,000 | -52.4% | 13,000 | 0.0% | 0.01% | -42.9% |
Q3 2018 | $372,000 | +4.5% | 13,000 | 0.0% | 0.02% | -4.5% |
Q2 2018 | $356,000 | – | 13,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |